1604 Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non-Renal Systemic Lupus Erythematosus

• Karen Costenbader,
• Yuqing Zhang,
• Hyon Choi,
• April Jorge,
• Emma Materne,
• Baijun Zhou

Affiliations

Karen Costenbader

Medicine, Brigham and Women`s Hospital, Boston, Massachusetts, USA

Yuqing Zhang

2 Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA

Hyon Choi

7 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA

April Jorge

1Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital

Emma Materne

3Department of Medicine, Massachusetts General Hospital

Baijun Zhou

1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital